Articles On Orthocell (ASX:OCC)

Highlights ASX 200 futures hint at a soft open amid global macro caution Fed maintains interest rates; inflation outlook revised upward Small-cap actions drive interest with regulatory approvals, trial updates The Australian share...

Medical device makers – including ASX-listed heart plays – are the likely winners from the US healthcare chaos Painchek hopes for US device approval by September Mayne Pharma flags legal action over Cosette bid but also waves an olive bra...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

Tylah Tully chats with Massachusetts General Hospital reconstructive surgeon, Harvard Professor and US Navy Captain Ian Valerio. Captain Valerio is a consultant and key opinion leader for Orthocell (ASX:OCC) and is visiting Australia to hel...

 Having produced more positive diagnostics results, Proteomics plans to launch its Promarker Endo device locally this year Immutep posts more positive trial results, this time for soft tissue sarcoma Broker values EBR Systems share price a...

Orthocell grows US distributors of its flagship nerve repair product Remplir to 12 Product granted US Food & Drug approval in April with signing of distributors ahead of schedule Remplir distributors now cover 21 US states with plans t...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Highlights  S&P/ASX200 poised to open higher following global equity rally  US-China tariff truce energizes tech, consumer, and mining sectors  Key updates from small caps including (ASX:OCC), (ASX:LVM), and (ASX:KAI)  Austral...

Orthocell receives regulatory approval to start sales of Remplir in the strategically important Hong Kong market Approval received well-ahead of initial expectations of Q4 2025 following submission in April Hong Kong approval adds to growi...

PEXA Group Ltd (ASX: PXA) shares are rising on Monday morning. At the time of writing, the property technology company's shares are up 0.5% to $11.89. What's going on with Pexa shares? Investors have been buying Pexa shares this morning aft...

Orthocell says it has moved at ‘warp speed’ to secure US distributors for its nerve repair device, marking another milestone in its commercialisation push into the world’s biggest healthcare market.

Highlights Orthocell (OCC) expands U.S. distribution network through 12 regional partners Australian Vanadium (AVL) progresses with Project Lumina's cost and design efficiency Forrestania Resources (FRS) reports drilling out...

The ASX200 has been up 0.45% at around 8,230 points. Orthocell (ASX:OCC) has been the most watched on HotCopper so far today, after appointing 12 distributors across 21 states in the U.S. The development is well ahead of expectations and...

Orthocell Ltd (ASX: OCC) shares are catching the eye again on Friday. In morning trade, the ASX All Ords stock is up 7% to $1.51. Why is this ASX All Ords stock jumping today? Investors have been buying the regenerative medicine company's s...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

The ASX energy share Woodside Energy Group Ltd (ASX: WDS) has had a rough time in the first few months of 2025. It's down close to 20% since the start of the year, as the chart below shows. Sometimes, large falls for commodity businesses ca...

Highlights: The ASX200 closed with a positive movement, reflecting growth across several sectors. The Information Technology and Real Estate sectors led the gains, while Utilities and Energy experienced declines. Companies l...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. In afternoon trade, the benchmark index is up slightly to 8,128.2 points. Four ASX shares that are rising more than most today are listed below. Here's why they are...

Are you on the lookout for ASX dividend shares to buy in May? If you are, then it could be worth checking out the two in this article that analysts are tipping as buys. Here's why they could be top buys this month: Cedar Woods Properties L...

Highlights: DY6 Metals (ASX:DY6) posted strong gallium assay results from its Malawi project, lifting its stock significantly Connected Minerals (ASX:CML) reported uranium exploration results from its Namibian prospect Intel...

You don't need thousands of dollars to be an investor — sometimes, all it takes is $500 and a plan. With markets constantly presenting new opportunities, even a small amount of capital can go a long way if you focus on quality businesses...

The S&P/ASX 200 Index (ASX: XJO) made it three for three this week on Wednesday, notching up its third positive session in a row. By the time the markets closed today, the ASX 200 had notched up a...

The ASX200 closed up 0.69% at 8,126 points. IT was the best performing sector, up 1.65%, followed by Real Estate, up 1.6%, and Discretionary and Health Care, both up 1.3%. Utilities was by far the worst performing sector, down 1.5%, f...

Tylah Tully speaks to Orthocell (ASX:OCC) chair John Van Der Wielen after the company reached another major milestone. Orthocell has now been granted access into the US$75 million Canadian market. This news comes hot on the heels of its re...

By stockpiling components, the US-focused Impedimed is taking no chances with tariffs Cashed-up Amplia forges ahead with promising pancreatic cancer trial Some biotechs are headed to the well, while others are rolling in the green stuff...

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up 0.1% to 8,081.1 points. Four ASX shares that have failed to follow the market higher today are listed below...

The S&P/ASX 200 Index (ASX: XJO) is having another positive session on Wednesday. At the time of writing, the benchmark index is up 0.2% to 8,086.6 points. Four ASX shares that are rising more than most today are listed below. Here's...

Orthocell has added Canada to its string of regulatory approvals for its flagship nerve repair product.

Highlights: ASX200 closed higher, led by strength in ASX Energy Stocks, IT, and Consumer Discretionary sectors Ainsworth Game Technology rose significantly after announcement of takeover by an Austrian firm Brambles and Lion...

ASX uranium stocks have soared after the US administration flagged U3O8 would be included in tariff exemption list Energy sector up more than 2pc, with Small Ords index close behind Utilities, Info Tech, Resources, Real Estate sectors all...

Highlights: Energy stocks led the ASX200 higher, while Materials lagged. Ainsworth Game Technology shares climbed following an acquisition announcement. Orthocell and Lynas Rare Earths posted gains on positive business updat...

Woodside Energy Group Ltd (ASX: WDS) shares are in the spotlight on Tuesday. That's because the energy giant has announced a major new investment decision that could reshape its future. At the time of writing, the company's shares are up 1%...

Orthocell gains regulatory approval for flagship nerve repair Remplir in lucrative Thai market Approval granted sooner than expected, unlocking door to growing $84 million Thai nerve repair market This tops off good month for Orthocell, wh...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.35% to 7,997.1 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

Key Highlights The ASX200 saw a moderate increase, driven by strength in Energy, IT, and Discretionary sectors. Ainsworth Game Technology experienced a significant rise after acquisition news. Brambles and Liontown Resources...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a positive start to the week's trading this Monday, despite an afternoon dip from the initial highs we saw this morning. By the time the markets closed, the...

The ASX200 closed up 0.36% at 7,997 points. The Energy sector lead the market higher, up 1.6%, followed by IT, up 1.4%, and Discretionary, up 1.3%. Materials was the only sector in the red, down 0.6%. In the Green Ainsworth Game...

WA biotech Orthocell has received the green light to start selling its nerve repair product into the Thai market, worth $131 million.

The S&P/ASX 200 Index (ASX: XJO) is starting the week on a positive note. At the time of writing, the benchmark index is up 0.7% to 8,023.9 points. Four ASX shares that have failed to follow the market higher today are listed below. He...

The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Monday. At the time of writing, the benchmark index is up 0.8% to 8,033.6 points. Four ASX shares that are rising more than most today are listed below. Here's why they are...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are tumbling on Monday morning. At the time of writing, the radiopharmaceuticals company's shares are down 8% to $26.35. Why are Telix shares sinking? Investors have been selling the company's sha...

Lynas Rare Earths Ltd (ASX: LYC) shares are catching the eye on Monday. At the time of writing, the rare earths producer's shares are up 3% to $8.56. Why are Lynas shares racing higher? Investors have been bidding Lynas shares higher today...

Every now and again, an ASX company emerges that captures the hearts and minds of investors.  It doesn't happen every year, but it certainly happens more often than you think.  From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to S...

Paladin Energy Ltd (ASX: PDN) shares have been on fire these past two days. On Wednesday, shares in the S&P/ASX 200 Index (ASX: XJO) uranium stock rocketed an eye-watering 24.6% following the release of the company's quarterly update....

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form and stormed higher. The benchmark index rose 1.3% to 7,920.5 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 expected to r...

The US Food and Drug Administration might be in a mess, but a slew of ASX biotechs can’t complain that the agency’s approval process has stalled. This month, the FDA approved Artrya’s (ASX:AYA) arterial plaque detection tool, Salix Coronary...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a hump day boost this Wednesday, rocketing higher following a surge of optimism out of the United States. By the time trading wrapped up today, the ASX 200...

Regenerative medicine developer Orthocell (ASX:OCC) has appointed the first four US distributors for its flagship nerve repair product Remplir. The appointments follow FDA clearance for Remplir which landed earlier this month, and Orthocell...

Regenerative medicine company Orthocell (ASX: OCC) has appointed the first four US distributors for the company’s flagship nerve repair product Remplir. The move follows regulatory clearance from the US Food and Drug Administration earlier...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.6% to 7,942.8 points. Four ASX shares that are rising more than most today are listed below....